Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
120
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy

Courtney TateDepartment of Haematology, Princess Alexandra Hospital, Woolloongabba, Australia; ;University of Queensland, St Lucia, Australia; Correspondence[email protected]
View further author information
,
Melinda BurgessTranslational Research Institute, Woolloongabba, Australia; View further author information
,
Nigel A. McMillanMenzies Health Institute Queensland, School of Medical Sciences, Griffith University, Southport, Australia; View further author information
,
Nicholas A. SaundersTranslational Research Institute, Woolloongabba, Australia; View further author information
,
Catherine CheungTranslational Research Institute, Woolloongabba, Australia; ;School of Medical Sciences, Griffith University, Southport, AustraliaView further author information
,
Devinder GillDepartment of Haematology, Princess Alexandra Hospital, Woolloongabba, Australia; View further author information
&
Peter MolleeDepartment of Haematology, Princess Alexandra Hospital, Woolloongabba, Australia; ;University of Queensland, St Lucia, Australia; View further author information
 show all
Pages 2563-2567 | Received 27 Jul 2018, Accepted 04 Feb 2019, Published online: 25 Jun 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

The authors would like to thank Professor Michael Hallek and Mr. Justin Scott.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1581936.

Additional information

Funding

This work was supported by a Leukaemia Foundation Australia Grant-In-Aid 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.